Skip to the page

Data / Form D filings / Accuitis Inc.

Accuitis Inc.: Form D filings

Accuitis Inc., a biotechnology company in Alpharetta, GA, filed 4 Form D notices with the SEC between 2015 and 2018. The latest, on August 31, 2018, reports $1 million sold of a $1 million offering to 22 investors.

Find out what Accuitis Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1005 ALDERMAN DRIVE, SUITE 104, Alpharetta, GA, 30005
Phone
(678) 812-1492
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Georgia
Revenue range
No Revenues
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1634848

The full lists. Form D filings in Georgia: 1,337 rows, $66.85, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Aug 31, 2018New notice$1,000,000$1,000,000$022Jan 31, 2018sec.gov
Sep 5, 2017Amendment$2,000,000$1,750,000$250,00015Jan 15, 2015sec.gov
Jul 1, 2016Amendment$1,500,000$1,000,000$500,00015Jan 15, 2015sec.gov
Mar 20, 2015New notice$750,000$495,000$255,00015Jan 15, 2015sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Geoff Jason MeachamDirector
Robert Jason ThomasDirector
Stephen Charles MartinDirector
Michael Charles ShippelExecutive Officer, Director
Richard Charles CoulonExecutive Officer, Director

Other biotechnology companies in Georgia that filed recently

Every Form D from the week of Aug 27, 2018 · All recent filings in Georgia · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Accuitis Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.